A term used to describe the set of DNA technologies that are utilized to generate a large number of samples of new chemicals (metabolites) via creation of non-natural metabolic pathways. This collection of samples thus generated, is called a “library,” and the samples are then tested for potential use (e.g., for therapeutic effect, in the case of pharmaceutical). These technologies enable greater efficiency in a pharmaceutical researcher’s screening process for drug discovery.